MedTrace Logo

Impact of Protein Formulations on the Stimulation of Muscle Protein Synthesis

NCT07501403 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-30

No results posted yet for this study

Summary

The overall objective of this study is to determine the effects of ingesting protein that slowly releases amino acids into the blood vs. a control product on how our muscles regulate the synthesis of new proteins, termed muscle protein synthesis (MPS), in healthy volunteers.

Conditions

  • Nutrition

Interventions

OTHER

Control Protein then Extended Release Nutritional Protein

Participants will consume a beverage with standard nutritional protein. Washout. Then participants will consume a beverage with extended release nutritional protein.

OTHER

Extended Release Protein then Control Nutritional Protein

Participants will consume a beverage with extended release nutritional protein. Washout. Then, participants will consume a beverage with control nutritional protein.

Sponsors & Collaborators

  • United States Department of Defense (DOD)

    collaborator UNKNOWN

  • Biofortis Clinical Research, Inc.

    collaborator INDUSTRY

  • VitaKey Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-07-31
Completion
2026-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501403 on ClinicalTrials.gov